Trajectories of Adherence to Airway Clearance Therapy for Patients with Cystic Fibrosis

Avani C. Modi(Cincinnati Children's Hospital Medical Center), Richard F. Ittenbach(Cincinnati Children's Hospital Medical Center), Amy Cassedy(Cincinnati Children's Hospital Medical Center), Alexandra L. Quittner(Joe DiMaggio Children's Hospital), Joyce M. Koenig(Saint Louis University), Marci K. Sontag(Colorado School of Public Health), Frank J. Accurso(University of Colorado Anschutz Medical Campus)
Journal of Pediatric Psychology
March 18, 2010
10.1093/jpepsy/jsq015
Cited by 74

Related Papers

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|496
Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections
|American Journal of Respiratory and Critical Care Medicine|2017|393
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis
|Journal of Clinical Investigation|2002|373
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis
|Journal of Clinical Investigation|2002|324